This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Switzer, R. C. Search for Related Content PubMed PubMed Citation Articles by Switzer, R. C. Social Bookmarking                         What's this?

Application of Silver Degeneration Stains for Neurotoxicity Testing

NeuroScience Associates, Knoxville, Tennessee 37922

Silver staining procedures have been used in numerous ways to render a variety of physical and biological features visible. In biological tissue, histologic protocols use silver to visualize diverse structures or features, such as reticulin, melanin, fungi, chromosome bands, nucleolar organizing regions, and different features in the nervous system. A comparison of the specific steps in these protocols indicates that the silver is "directed" to stain any given feature by the type of fixation, the pretreatment ("mordanting"), the composition of the silver-containing solution(s), and the form of development (reduction). Since the mechanisms of staining have not been understood historically (nor are they now), each method was developed by trial and error. Keystone methods such as those of Bodian and Bielschowsky exploit the nervous system's affinity for silver (argyrophilia). The beginning of a new era in brain research came with the recognition that distinct silver-impregnated morphologic changes occurring in damaged axons could be used for tracing axon pathways in experimental animals with specifically placed lesions. Improvements in staining methods used to selectively impregnate the disintegrating axons but to leave normal axons unstained were achieved by Nauta and Gygax (early workers with these procedures) and spawned a host of method variations known as the "Nauta" methods. Of these, the Fink-Heimer and de Olmos cupric-silver methods were able to unambiguously demonstrate disintegrating synaptic terminals, thereby allowing complete tracing of axon pathways. The late 1970s and 1980s witnessed innovative applications of these techniques. The silver methods once used to trace axon pathways became indicators of the extreme endpoint of neurotoxicity: disintegrative degeneration of neurons induced by neurotoxic chemicals that were administered systemically. The hallmark of neurotoxic substances is the selectivity with which each destroys specific populations or subpopulations of neurons. The high contrast and sensitivity of the silver degeneration stains greatly facilitate the screening process to detect these affected populations, especially when there is no basis for knowing where in the brain to look for damage. More recently, in addition to expanded use in screening for neurotoxic effects, the silver degeneration stains are being used to chart the neuron populations undergoing programmed cell death in the developing brain. Other newly developed silver methods have been refined to show nondisintegrative degeneration, such as the plaques and tangles of Alzheimer's disease.

Key Words: Amino cupric silver • apoptosis • brain • electron microscopy • fragmentation of proteins • MultiBrain Technology • neural tracing • neurohistology • neurotoxins • risk assessment

Toxicologic Pathology, Vol. 28, No. 1, 70-83 (2000)
DOI: 10.1177/019262330002800109


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. T. Crews and K. Nixon Mechanisms of Neurodegeneration and Regeneration in Alcoholism Alcohol Alcohol., March 1, 2009; 44(2): 115 - 127. [Abstract] [Full Text] [PDF]

				B. Bolon, D. C. Anthony, M. Butt, D. Dorman, M. V. Green, P. B. Little, W. M. Valentine, D. Weinstock, J. Yan, and R. C. Sills "Current Pathology Techniques" Symposium Review: Advances and Issues in Neuropathology Toxicol Pathol, October 1, 2008; 36(6): 871 - 889. [Abstract] [Full Text] [PDF]

				K. A. Hamilton, S. Parrish-Aungst, F. L. Margolis, F. Erdelyi, G. Szabo, and A. C. Puche Sensory Deafferentation Transsynaptically Alters Neuronal GluR1 Expression in the External Plexiform Layer of the Adult Mouse Main Olfactory Bulb Chem Senses, February 1, 2008; 33(2): 201 - 210. [Abstract] [Full Text] [PDF]

				R. F. Berman, I. N. Pessah, P. R. Mouton, D. Mav, and J. Harry Low-Level Neonatal Thimerosal Exposure: Further Evaluation of Altered Neurotoxic Potential in SJL Mice Toxicol. Sci., February 1, 2008; 101(2): 294 - 309. [Abstract] [Full Text] [PDF]

				H.-X. Deng, H. Zhai, R. Fu, Y. Shi, G. H. Gorrie, Y. Yang, E. Liu, M. C. Dal Canto, E. Mugnaini, and T. Siddique Distal axonopathy in an alsin-deficient mouse model Hum. Mol. Genet., December 1, 2007; 16(23): 2911 - 2920. [Abstract] [Full Text] [PDF]

				C. Hamelink, A. Hampson, D. A. Wink, L. E. Eiden, and R. L. Eskay Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 780 - 788. [Abstract] [Full Text] [PDF]

				J. Callio, T. D. Oury, and C. T. Chu Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains J. Biol. Chem., May 6, 2005; 280(18): 18536 - 18542. [Abstract] [Full Text] [PDF]

				S. M. Adams, J. C. de Rivero Vaccari, and R. A. Corriveau Pronounced Cell Death in the Absence of NMDA Receptors in the Developing Somatosensory Thalamus J. Neurosci., October 20, 2004; 24(42): 9441 - 9450. [Abstract] [Full Text] [PDF]

				D. E. Sleat, J. A. Wiseman, M. El-Banna, K.-H. Kim, Q. Mao, S. Price, S. L. Macauley, R. L. Sidman, M. M. Shen, Q. Zhao, et al. A Mouse Model of Classical Late-Infantile Neuronal Ceroid Lipofuscinosis Based on Targeted Disruption of the CLN2 Gene Results in a Loss of Tripeptidyl-Peptidase I Activity and Progressive Neurodegeneration J. Neurosci., October 13, 2004; 24(41): 9117 - 9126. [Abstract] [Full Text] [PDF]

				K. Carlson and M. Ehrich Organophosphorus Compound-Induced Delayed Neurotoxicity in White Leghorn Hens Assessed by Fluoro-Jade International Journal of Toxicology, July 1, 2004; 23(4): 259 - 266. [Abstract] [Full Text] [PDF]

				L. Heimer A New Anatomical Framework for Neuropsychiatric Disorders and Drug Abuse Am J Psychiatry, October 1, 2003; 160(10): 1726 - 1739. [Abstract] [Full Text] [PDF]

				R. H. Garman Evaluation of Large-Sized Brains for Neurotoxic Endpoints Toxicol Pathol, January 1, 2003; 31(1_suppl): 32 - 43. [Abstract] [PDF]

				Z. Cheng, S. Z. Guo, A. J. Lipton, and D. Gozal Domoic Acid Lesions in Nucleus of the Solitary Tract: Time-Dependent Recovery of Hypoxic Ventilatory Response and Peripheral Afferent Axonal Plasticity J. Neurosci., April 15, 2002; 22(8): 3215 - 3226. [Abstract] [Full Text] [PDF]

				B. Bolon Comparative and Correlative Neuroanatomy for the Toxicologic Pathologist Toxicol Pathol, January 1, 2000; 28(1): 6 - 27. [Abstract] [PDF]

				A. S. Fix, S. R. Stitzel, G. M. Ridder, and R. C. Switzer MK-801 Neurotoxicity in Cupric Silver-Stained Sections: Lesion Reconstruction by 3-Dimensional Computer Image Analysis Toxicol Pathol, January 1, 2000; 28(1): 84 - 90. [Abstract] [PDF]